NCT04396821 2025-12-17A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsSuzhou Transcenta Therapeutics Co., Ltd.Phase 1/2 Active not recruiting150 enrolled
NCT07139587 2025-09-10The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaHebei General HospitalPhase NA Not yet recruiting30 enrolled
NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts